Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Gino In

    TitleAssistant Professor of Clinical Medicine
    SchoolKeck School of Medicine of USC
    AddressGNH 3821
    Health Sciences Campus
    Los Angeles California 90089-9324
    Phone+1 323 226 7622
    vCardDownload vCard

      Collapse Overview 
      Collapse Overview
      Gino K. In is a medical oncologist who specializes in solid tumor and cutaneous oncology. He completed his residency training in hematology and oncology at the University of Southern California Keck School of Medicine, where he was the chief medical oncology fellow. He has stayed on to serve as Assistant Professor of Medicine in the Division of Oncology.

      Dr. In’s research focus includes the multi-disciplinary management of melanoma and other skin cancers, with a specific interest in improving cancer outcomes among underserved populations, including adolescents and young adults, and Hispanics. He is actively involved with the USC Adolescent and Young Adult (AYA) Oncology Group, the USC Skin Cancer Task Force, and the Melanoma Prevention Working Group.

      Collapse Biography 
      Collapse Education and Training
      University of Southern California, Los Angeles, CAFellowship2016Hematology/Oncology
      SUNY Downstate Medical Center, Brooklyn, NYResidency2011Internal Medicine
      SUNY Downstate Medical Center, Brooklyn, NYInternship2010
      Ross University, North Brunswick Township, NJMD2010Medicine
      Emory University, Atlanta, GAMPH2006Environmental/Occupational Health
      Emory University, Atlanta, GABS2002
      Collapse Awards and Honors
      University of Southern CaliforniaChief Medical Oncology Fellow

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. In G, Mason J, Lin S, Newton P, Kuhn P, Nieva J. Development of metastatic brain disease involves progression through lung metastases in EGFR mutated non-small cell lung cancer. Convergent Science Physical Oncology. 2017; 3(3).
      2. Miller KA, In G, Jiang SY, Ahadiat O, Higgins S, Wysong A, Cockburn MG. Skin Cancer Prevention Among Hispanics: a Review of the Literature. Epidemiology. 2017.
      3. In G, Hu JS, Tseng WW. Treatment of advanced, metastatic soft tissue sarcoma: latest evidence and clinical considerations. Ther Adv Med Oncol. 2017 Aug; 9(8):533-550. PMID: 28794805.
        View in: PubMed
      4. In G, Dorff T. Chemotherapy for Good-Risk Nonseminomatous Germ Cell Tumors: Current Concepts and Controversies. Urol Clin North Am. 2015 Aug; 42(3):347-57. PMID: 26216822.
        View in: PubMed
      5. In G, Nieva J. Emerging Chemotherapy Agents in Lung Cancer: Nanoparticle Therapeutics for Non-Small Cell Lung Cancer. Transl Cancer Res. 2015; 4(4):340-355.